Effects of Nordic Walking on Prenatal Health (Nordic Walking)

July 7, 2025 updated by: Wafaa Mahmoud Amin, University of Jazan

Effects of Nordic Walking on Prenatal Health: A Focus on Gait Kinematics, Musculoskeletal Pain, and Quality of Life. A Randomized Controlled Trial.

This randomized controlled trial (RCT) aimed to evaluate the effects of Nordic walking (NW) on gait kinematics, musculoskeletal pain, and quality of life in pregnant women.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Healthy pregnant women (N=50), aged 20-40 years and between 13 and 28 weeks of gestation, experiencing mild to moderate musculoskeletal pain, will be recruited. Participants will be randomized into either an intervention group (NW training) or a control group receiving standard prenatal care. The intervention group will undergo a 4-week learning phase followed by an 8-week NW program (3 sessions per week, 45 minutes per session), led by a certified instructor. Outcome measures will be assessed at baseline, after 4 weeks, and post-intervention (8 weeks), including spatiotemporal gait parameters (will be assessed using the GAITRite system), musculoskeletal pain (will be measured via Visual Analog Scale, VAS), and quality of life (will be measured using the SF-36 Health Survey).

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alkharj
      • Riyadh, Alkharj, Saudi Arabia, 11942
        • Department of Health and Rehabilitation Sciences, Prince Sattam bin Abdulaziz University.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy women aged 20 to 40 between 13 and 28 weeks into singleton pregnancy.
  • Participants must be experiencing mild to moderate musculoskeletal discomfort, such as lower back or pelvic pain,
  • Participants have no prior musculoskeletal or neurological diseases.
  • They must have no contraindications to exercising throughout pregnancy, as established by obstetrician clearance, and be able to engage in moderate physical activity under medical recommendations

Exclusion Criteria:

  • History of diseases affecting bony structures or lumbar intervertebral discs.
  • Pain caused by non-musculoskeletal factors (such as urinary tract infections or obstetric complications).
  • Multiple pregnancies, pre-existing mobility conditions, and high-risk pregnancies or complications that restrict physical activity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
It will be receiving Nordic walking training
Traditional Nordic walking poles will be modified according to International Nordic Walking Federation guidelines, which meant that the elbows were bent at a 90°angle when holding the poles in a vertical position. Nordic Walking will be conducted in two phases consisting of a 4-week learning phase followed by an 8-week main phase of intervention.
No Intervention: Control Group
This group will receive a standard prenatal care, which included routine obstetric check-ups and general advice on physical activity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spatial gait parameters
Time Frame: 20 minutes
A GAITRite system will be used to assess the spatial parameters of gait
20 minutes
Temporal parameters of gait
Time Frame: 20 minutes
A GAITRite system will be used to assess the temporal parameters of gait
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Score for musculoskeletal pain
Time Frame: 5 minutes
The Visual Analog Score is depicted as a 10 cm horizontal line divided into 1 cm sections, each representing 1 point, resulting in a score ranging from 0 to 10 points. Higher scores mean worse outcome.
5 minutes
Quality of life
Time Frame: 10 minutes
The SF-36 Health Survey will be used to determine the results.
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nadia L Radwan, PHD, Prince Sattam Bin Abdulaziz University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2024

Primary Completion (Actual)

May 6, 2025

Study Completion (Actual)

June 29, 2025

Study Registration Dates

First Submitted

November 1, 2024

First Submitted That Met QC Criteria

November 1, 2024

First Posted (Actual)

November 4, 2024

Study Record Updates

Last Update Posted (Estimated)

July 8, 2025

Last Update Submitted That Met QC Criteria

July 7, 2025

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RHPT/024/016 (Other Identifier: Prince Sattam bin Abdulaziz University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Walking

Clinical Trials on Prenatal Nordic Walking

Subscribe